VT News
Christine D'Clario

Christine D'Clario

Ask VT AI
View News Summary
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges, including declining cigarette volumes and e-vapor headwinds.
  • Stellantis reports strong Q3 results, but warns of one-off charges and potential challenges ahead.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
  • Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges, including declining cigarette volumes and e-vapor headwinds.
  • Stellantis reports strong Q3 results, but warns of one-off charges and potential challenges ahead.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Christine D'Clario

Top Topics

Trending in U.S.

World

Sport